Article

Lifestyle Intervention Slows Mobility Loss in Obese Adults With Diabetes

For overweight and obese adults with type 2 diabetes, losing weight and improving fitness can reduce limitations in mobility.

An intervention that results in weight loss and improved fitness may slow the decline in mobility that often occurs with aging in overweight and obese adults with type 2 diabetes mellitus (DM). The intervention may be most effective in reducing severe disability.

Rejeski and associates randomly assigned 5145 overweight or obese adults aged 45 to 74 years with type 2 DM to an intensive lifestyle intervention or a DM support and education program. The primary outcome was self-reported limitation in mobility, with annual assessments for 4 years.

At year 4, 20.6% of patients in the lifestyle-intervention group had severe disability and 38.5% had good mobility, compared with 26.2% and 31.9% of patients in the support group. The intervention group had a relative reduction of 48% in the risk of loss of mobility compared with the support group. Weight loss and improved fitness were significant mediators of this effect. Adverse events related to the lifestyle intervention included a slightly higher frequency of musculoskeletal symptoms at year 1.

The authors noted that theirs are the first data from the Look AHEAD (Action for Health in Diabetes) study to show that an intensive lifestyle intervention reduces the risk of loss of mobility.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.